PE Tech Report


Like this article?

Sign up to our free newsletter

Linden Capital Partners raises USD1.5bn for Fund IV

Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm, has closed its fourth private equity fund, Linden Capital Partners IV (Fund IV), with USD1.5 billion of limited partner commitments.

Similar to Linden’s prior funds, Fund IV was oversubscribed, exceeding its target of USD1.25 billion and hitting its hard cap. “We truly appreciate the support from our investors, which include endowments, global financial institutions, and pension funds,” says Linden President and Managing Partner, Tony Davis. “Linden will continue to execute its consistent strategy in Fund IV. This strategy consists of implementing its proprietary value creation programs, emphasising human capital, and leveraging the integrated expertise of its operating partners and investment professionals to build market-leading healthcare companies.”
Since its inaugural fund in 2005, Linden has pursued an investment strategy in private equity focused on adding significant value to middle market healthcare companies in the services, medical products, specialty distribution, and pharmaceutical sectors, among others. Linden expanded its resources throughout the deployment phase of its third fund, including the addition of four new investment professionals, five new operating partners, and an additional member to the firm’s finance team.
Linden Capital Partners closed its first fund of USD200 million in 2005, its second fund of USD375 million in 2010, and its third fund of USD750 million in 2015. 
Kirkland & Ellis LLP served as legal advisors and Park Hill Group LLC served as placement advisor.

Like this article? Sign up to our free newsletter